Vicore Pharma (Sweden) Market Value
| VICO Stock | SEK 7.92 0.32 3.88% |
| Symbol | Vicore |
Vicore Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vicore Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vicore Pharma.
| 03/12/2023 |
| 03/01/2025 |
If you would invest 0.00 in Vicore Pharma on March 12, 2023 and sell it all today you would earn a total of 0.00 from holding Vicore Pharma Holding or generate 0.0% return on investment in Vicore Pharma over 720 days. Vicore Pharma is related to or competes with Addtech AB, Lundin Mining, Raketech Group, USWE Sports, Investment, and Vitec Software. Vicore Pharma Holding AB , through its subsidiaries, operates as a biotech company More
Vicore Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vicore Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vicore Pharma Holding upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.55 | |||
| Information Ratio | 0.0278 | |||
| Maximum Drawdown | 16.91 | |||
| Value At Risk | (4.39) | |||
| Potential Upside | 5.29 |
Vicore Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vicore Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vicore Pharma's standard deviation. In reality, there are many statistical measures that can use Vicore Pharma historical prices to predict the future Vicore Pharma's volatility.| Risk Adjusted Performance | 0.0251 | |||
| Jensen Alpha | 0.0404 | |||
| Total Risk Alpha | 0.1607 | |||
| Sortino Ratio | 0.034 | |||
| Treynor Ratio | (0.06) |
Vicore Pharma Holding Backtested Returns
Currently, Vicore Pharma Holding is slightly risky. Vicore Pharma Holding owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0374, which indicates the firm had a 0.0374 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Vicore Pharma Holding, which you can use to evaluate the volatility of the company. Please validate Vicore Pharma's Coefficient Of Variation of 4224.68, semi deviation of 2.5, and Risk Adjusted Performance of 0.0251 to confirm if the risk estimate we provide is consistent with the expected return of 0.12%. Vicore Pharma has a performance score of 2 on a scale of 0 to 100. The entity has a beta of -1.01, which indicates a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Vicore Pharma are expected to decrease slowly. On the other hand, during market turmoil, Vicore Pharma is expected to outperform it slightly. Vicore Pharma Holding right now has a risk of 3.13%. Please validate Vicore Pharma downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if Vicore Pharma will be following its existing price patterns.
Auto-correlation | 0.64 |
Good predictability
Vicore Pharma Holding has good predictability. Overlapping area represents the amount of predictability between Vicore Pharma time series from 12th of March 2023 to 6th of March 2024 and 6th of March 2024 to 1st of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vicore Pharma Holding price movement. The serial correlation of 0.64 indicates that roughly 64.0% of current Vicore Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.64 | |
| Spearman Rank Test | 0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 27.22 |
Vicore Pharma Holding lagged returns against current returns
Autocorrelation, which is Vicore Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vicore Pharma's stock expected returns. We can calculate the autocorrelation of Vicore Pharma returns to help us make a trade decision. For example, suppose you find that Vicore Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Vicore Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vicore Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vicore Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vicore Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
Vicore Pharma Lagged Returns
When evaluating Vicore Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vicore Pharma stock have on its future price. Vicore Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vicore Pharma autocorrelation shows the relationship between Vicore Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Vicore Pharma Holding.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Vicore Stock Analysis
When running Vicore Pharma's price analysis, check to measure Vicore Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicore Pharma is operating at the current time. Most of Vicore Pharma's value examination focuses on studying past and present price action to predict the probability of Vicore Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicore Pharma's price. Additionally, you may evaluate how the addition of Vicore Pharma to your portfolios can decrease your overall portfolio volatility.